. In the United States, anticoagulation is used selectively in vein bypass procedures
with either suboptimal conduit or compromised runoff.
Warfarin in addition to ASA is used in many patients
receiving prosthetic grafts to reduce the ischemic consequences of bypass graft thrombosis. However, caution is
warranted given the incremental bleeding risks associated
with combination therapy, and existing evidence is inadequate to support a deÔ¨Ånitive recommendation at this time.

JOURNAL OF